Edwards profit up on strong sales of new heart valve
Feb 4 (Reuters) - Edwards Lifesciences Corp posted on Monday higher fourth-quarter earnings on strong sales of its artificial heart valve that is implanted in a less-invasive procedure than open-heart surgery.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here